The psychopharmacologic drug classification of Olanzapine is

ESIC Nursing Officer-7July 2024

Pharmacology

Easy

Appeared in: ESIC Nursing Officer-7July 2024

Explanation

Olanzapine is classified as a second-generation (atypical) antipsychotic, used primarily for treating schizophrenia and bipolar disorder.
Its mechanism of action involves antagonism of both dopamine (D2) and serotonin (5-HT2A) receptors.
This dual blockade is effective for both positive and negative symptoms of schizophrenia and carries a lower risk of extrapyramidal symptoms (EPS) compared to typical antipsychotics.

Option A: Typical antipsychotics (e.g., haloperidol) are first-generation agents that primarily block D2 receptors and have a high risk of EPS. Olanzapine's mechanism and side effect profile are different.
Option C: Antidepressants (e.g., SSRIs, TCAs) are a distinct class of drugs used to treat depression. While olanzapine can be used in combination to treat depression, it is not its primary classification.
Option D: While olanzapine is used as a mood-stabilizing agent in bipolar disorder, its primary pharmacological class is antipsychotic. The term 'mood stabilizer' typically refers to drugs like lithium, valproate, and lamotrigine.

Visual 1: Diagram: A visual comparing the receptor binding profiles of typical antipsychotics (high D2 blockade) versus atypical antipsychotics like olanzapine (D2 and 5-HT2A blockade).
Visual 2: Table: A summary table of common first-generation and second-generation antipsychotics with their key side effects (EPS vs. Metabolic Syndrome).
Visual 3: Flowchart: A decision tree for selecting an antipsychotic, considering factors like patient symptoms (positive vs. negative) and risk factors for side effects.

Clinical Relevance

Nursing practice connection: Knowing Pharmacological classification of antipsychotic medications helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
A key nursing responsibility is monitoring for metabolic syndrome in patients taking olanzapine. This includes tracking weight, waist circumference, blood pressure, fasting glucose, and lipid levels.
Patient education is crucial. Nurses must teach patients and families about the importance of a healthy diet, regular exercise, and adherence to monitoring appointments to mitigate the risk of weight gain and diabetes.
What if? If a patient on olanzapine shows a rapid and significant weight gain of more than 5% of their baseline body weight within the first month, the nurse must promptly report this to the healthcare provider. This may necessitate a medication review or initiation of metabolic interventions.

How to Approach the Question

First, identify the drug name in the question stem: 'Olanzapine'.
Next, recognize that the question asks for its 'psychopharmacologic drug classification', which is a test of factual recall from pharmacology.
Recall or deduce the major categories of psychotropic drugs: antipsychotics, antidepressants, mood stabilizers, anxiolytics, etc.
Mentally place Olanzapine into its correct category. Remember that it is a newer antipsychotic, which places it in the 'atypical' or 'second-generation' class.
Evaluate the given options. 'Atypical antipsychotic' is a direct match. Differentiate it from 'Typical antipsychotic' based on generation and side effect profile, and from 'Antidepressant' and 'Mood stabilizer' based on primary function.

Concept Tested & Keywords

Qr8A0khTdN0-erVNJ-Ak4M